URGN EPS Estimates
UroGen Pharma Ltd.
$25.44
-$0.87(-3.31%)
42
Overall
40
Value
27
Tech
60
Quality
Market Cap
$1.25B
Volume
146.75K
52W Range
$16.50 - $50.81
Target Price
$56.89
URGN EPS estimates: the consensus estimate for UroGen Pharma Ltd.'s current fiscal year is -$0.36 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
URGN EPS Estimates
- EPS estimate, current quarter
- $0.41
- EPS estimate, next quarter
- $0.09
- EPS estimate, current year
- $-0.36
- EPS estimate, next year
- $2.63
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2021 | $-4.96 |
| 2020 | $-5.90 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $25.44 | -3.3% | 146.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |